Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review
Annals of the New York Academy of Sciences · 2025
DOI: 10.1111/nyas.70066 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of the New York Academy of Sciences, 2025. Verfasst von Mohaddese Mohaddesi Khorasani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedics Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Osteogenesis Imperfecta. Die Arbeit nennt 109 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
The following systematic review provides an evaluation of the effectiveness of mesenchymal stem cell (MSC) transplantation in the treatment of osteogenesis imperfecta (OI). After reviewing 40 studies, 9 human clinical studies that included case reports or case series were included and resulted in a total of 12 patients with OI. Five studies documented an increase in total body bone mineral (TBBM) content, whereas four studies observed a reduction in fracture rates post‐transplantation. Moreover, noticeable improvements in children's growth were recorded. Although both BMSCs and human fetal MSCs (hfMSCs) were found to be effective, studies involving BMSCs were rated higher in terms of methodological quality. Both BMSCs and hfMSCs demonstrated significant improvements in TBBM, growth rates, and fracture reduction, with BMSC studies scoring higher in methodological quality. Future randomized clinical trials with longer follow‐ups are necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthopedics Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran.
- Bone and Joint Research Laboratory, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
- Clinical Development Research Unit, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Regenerative Medicine and Cell Therapy, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Nafiseh Jirofti
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Khorasani, M. M., Ebrahimzadeh, M. H., Dehghani, M., Sharafoddin, M., Moradi, A., & Jirofti, N. (2025). Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.70066
Vancouver
Khorasani MM, Ebrahimzadeh MH, Dehghani M, Sharafoddin M, Moradi A, Jirofti N. Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review. Annals of the New York Academy of Sciences. 2025. doi:10.1111/nyas.70066
BibTeX
@article{Khorasani2025,
author = {Khorasani, Mohaddese Mohaddesi and Ebrahimzadeh, Mohammad Hossein and Dehghani, Mohsen and Sharafoddin, Maedeh and Moradi, Ali and Jirofti, Nafiseh},
title = {Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review},
journal = {Annals of the New York Academy of Sciences},
year = {2025},
doi = {10.1111/nyas.70066}
}
EUVIMED